Commonwealth Equity Services
TXG icon

Commonwealth Equity Services’s 10x Genomics TXG Stock Holding History

Commonwealth Equity Services’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Buy
+9,308
New +$244K ﹤0.01% 3619
2025
Q3 		– Sell
-13,673
Closed -$158K – 4433
2025
Q2 		$158K Buy
+13,673
New +$125K ﹤0.01% 3980
2025
Q1 		– Sell
-10,137
Closed -$146K – 4288
2024
Q4 		$146K Buy
+10,137
New +$160K ﹤0.01% 3836
2024
Q2 		– Sell
-5,526
Closed -$207K – 4173
2024
Q1 		$207K Sell
5,526
-30
-0.5% -$1.32K ﹤0.01% 3598
2023
Q4 		$311K Sell
5,556
-1,637
-23% -$71.2K ﹤0.01% 3139
2023
Q3 		$297K Buy
7,193
+1,486
+26% +$77.3K ﹤0.01% 3042
2023
Q2 		$319K Sell
5,707
-323
-5% -$17.5K ﹤0.01% 2998
2023
Q1 		$336K Sell
6,030
-1,498
-20% -$70K ﹤0.01% 2864
2022
Q4 		$274K Sell
7,528
-30
-0.4% -$981 ﹤0.01% 2944
2022
Q3 		$215K Sell
7,558
-24
-0.3% -$914 ﹤0.01% 3107
2022
Q2 		$343K Sell
7,582
-1,684
-18% -$87.4K ﹤0.01% 2720
2022
Q1 		$704K Sell
9,266
-147
-2% -$12.9K ﹤0.01% 2258
2021
Q4 		$1.4M Buy
9,413
+47
+0.5% +$7.2K ﹤0.01% 1742
2021
Q3 		$1.36M Sell
9,366
-1,626
-15% -$279K ﹤0.01% 1704
2021
Q2 		$2.15M Sell
10,992
-7
-0.1% -$1.27K 0.01% 1376
2021
Q1 		$1.99M Buy
10,999
+693
+7% +$120K 0.01% 1327
2020
Q4 		$1.46M Buy
10,306
+240
+2% +$34.8K ﹤0.01% 1414
2020
Q3 		$1.25M Buy
+10,066
New +$1.06M ﹤0.01% 1362

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Commonwealth Equity Services's TXG Position: Q2 2026 in Review

Commonwealth Equity Services opened a new position in 10x Genomics (TXG) in Q2 2026: 9,308 shares worth $357K. The stake represents ﹤0.01% of the portfolio and ranks #3619 among its holdings. This is a return to the name: Commonwealth Equity Services previously reported a position in TXG as recently as Q2 2025.

Commonwealth Equity Services first reported a position in TXG in Q3 2020 and has held it in 18 quarters since. The position peaked at $2.15M in Q2 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Commonwealth Equity Services held 9,308 shares of 10x Genomics worth $357K as of Q2 2026.
  • 10x Genomics was a new Commonwealth Equity Services position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3619 holding.
  • Commonwealth Equity Services first reported a position in 10x Genomics in Q3 2020 and has held it in 18 quarters since.
  • Commonwealth Equity Services's 10x Genomics position peaked at $2.15M in Q2 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.